Controlled release nanoplatforms for three commonly used chemotherapeutics

Joel Costoya, Bapurao Surnar, Akil A. Kalathil, Nagesh Kolishetti, Shanta Dhar

Research output: Contribution to journalArticlepeer-review


In order to combat an evolving, multidimensional disease such as cancer, research has been aimed at synthesizing more efficient and effective versions of popular chemotherapeutic drugs. Despite these efforts, there remains a necessity for the development of suitable delivery vehicles that can both harness the chemotherapeutic effects meanwhile reducing some of the known issues when using these drugs such as unwanted side-effects, acquired drug resistance, and associated difficulties with drug delivery. Synthetic drug discovery approaches focusing on modification of the native structure of these chemotherapeutic drugs often face challenges such as loss of efficacy, as well as a potential worsening of side-effects. Synthetic chemists are then left with increasingly narrow choices for possible chemistry they could implement to achieve the desired therapy. The emergence of targeted therapies using controlled-release nanomaterials can provide many opportunities for conventional chemotherapeutic drugs to be delivered to specific target sites, ultimately leading to reduced side-effects and improved efficacy. Logically, it may prove advantageous to consider nano-delivery systems as a likely candidate for circumventing some of the barriers associated with creating viable drug therapies. In this review, we summarize controlled release nanoformulations of the three most widely used and approved chemotherapeutics, doxorubicin, paclitaxel, and cisplatin as an alternative therapeutic approach against different cancer types.

Original languageEnglish (US)
Article number101043
JournalMolecular Aspects of Medicine
StateAccepted/In press - 2021
Externally publishedYes


  • Cancer therapy
  • Cisplatin
  • Clinical trials
  • Doxorubicin
  • Nanotherapeutic platform
  • Taxol®

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry


Dive into the research topics of 'Controlled release nanoplatforms for three commonly used chemotherapeutics'. Together they form a unique fingerprint.

Cite this